Request for Covid-19 Impact Assessment of this Report
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness."
Scope of the Report:
This report focuses on the Latanoprost in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Market Segment by Countries, covering
United States
Canada
Mexico
Market Segment by Type, covers
Brand Drug
Generic Drug
Market Segment by Applications, can be divided into
Open-angle Glaucoma
Close-angle Glaucoma
There are 15 Chapters to deeply display the North America Latanoprost market.
Chapter 1, to describe Latanoprost Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Latanoprost, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Latanoprost, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Latanoprost market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Latanoprost Research Findings and Conclusion, Appendix, methodology and data source
1 Market Overview
1.1 Latanoprost Introduction
1.2 Market Analysis by Type
1.2.1 Brand Drug
1.2.2 Generic Drug
1.3 Market Analysis by Applications
1.3.1 Open-angle Glaucoma
1.3.2 Close-angle Glaucoma
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Profile
2.1.2 Latanoprost Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Pfizer News
2.2 Mylan
2.2.1 Profile
2.2.2 Latanoprost Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Mylan News
2.3 Novartis
2.3.1 Profile
2.3.2 Latanoprost Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Novartis News
2.4 Apotex
2.4.1 Profile
2.4.2 Latanoprost Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Apotex News
2.5 Teva
2.5.1 Profile
2.5.2 Latanoprost Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Teva News
2.6 Taj Pharma
2.6.1 Profile
2.6.2 Latanoprost Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Taj Pharma News
2.7 CR Zizhu
2.7.1 Profile
2.7.2 Latanoprost Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 CR Zizhu News
3 North America Latanoprost Market Competition, by Manufacturer
3.1 North America Latanoprost Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Latanoprost Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Latanoprost Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Latanoprost Manufacturer Market Share
3.4.2 Top 5 Latanoprost Manufacturer Market Share
3.5 Market Competition Trend
4 North America Latanoprost Market Analysis by Countries
4.1 North America Latanoprost Sales Market Share by Countries
4.2 North America Latanoprost Sales by Countries (2012-2017)
4.3 North America Latanoprost Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Latanoprost by Type
5.1 North America Latanoprost Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Latanoprost Sales and Market Share by Type (2012-2017)
5.1.2 North America Latanoprost Revenue and Market Share by Type (2012-2017)
5.2 Brand Drug Sales Growth and Price
5.2.1 North America Brand Drug Sales Growth (2012-2017)
5.2.2 North America Brand Drug Price (2012-2017)
5.3 Generic Drug Sales Growth and Price
5.3.1 North America Generic Drug Sales Growth (2012-2017)
5.3.2 North America Generic Drug Price (2012-2017)
6 North America Market Segmentation Latanoprost by Application
6.1 North America Latanoprost Sales Market Share by Application (2012-2017)
6.2 Open-angle Glaucoma Sales Growth (2012-2017)
6.3 Close-angle Glaucoma Sales Growth (2012-2017)
7 United States Latanoprost Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Latanoprost Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Latanoprost Sales and Market Share by Type
7.3 United States Latanoprost Sales by Application (2012-2017)
7.4 United States Latanoprost Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Latanoprost Sales and Market Share by Manufacturer
7.4.2 United States Latanoprost Revenue and Market Share by Manufacturer
7.5 United States Latanoprost Export and Import (2012-2017)
8 Canada Latanoprost Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Latanoprost Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Latanoprost Sales and Market Share by Type
8.3 Canada Latanoprost Sales by Application (2012-2017)
8.4 Canada Latanoprost Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Latanoprost Sales and Market Share by Manufacturer
8.4.2 Canada Latanoprost Revenue and Market Share by Manufacturer
8.5 Canada Latanoprost Export and Import (2012-2017)
9 Mexico Latanoprost Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Latanoprost Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Latanoprost Sales and Market Share by Type
9.3 Mexico Latanoprost Sales by Application (2012-2017)
9.4 Mexico Latanoprost Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Latanoprost Sales and Market Share by Manufacturer
9.4.2 Mexico Latanoprost Revenue and Market Share by Manufacturer
9.5 Mexico Latanoprost Export and Import (2012-2017)
10 Latanoprost Market Forecast (2017-2022)
10.1 North America Latanoprost Sales, Revenue and Growth Rate (2017-2022)
10.2 Latanoprost Market Forecast by Countries (2017-2022)
10.2.1 United States Latanoprost Forecast (2017-2022)
10.2.2 Canada Latanoprost Forecast (2017-2022)
10.2.3 Mexico Latanoprost Forecast (2017-2022)
10.3 Latanoprost Market Forecast by Type (2017-2022)
10.4 Latanoprost Market Forecast by Application (2017-2022)
11 Latanoprost Manufacturing Cost Analysis
11.1 Latanoprost Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Latanoprost
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Latanoprost Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Latanoprost Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
Figure Latanoprost Picture
Table Product Specifications of Latanoprost
Figure North America Sales Market Share of Latanoprost by Types in 2016
Table Types of Latanoprost
Figure Brand Drug Picture
Table Major Manufacturers of Brand Drug
Figure Generic Drug Picture
Table Major Manufacturers of Generic Drug
Table North America Latanoprost Sales Market Share by Applications in 2016
Table Applications of Latanoprost
Figure Open-angle Glaucoma Picture
Figure Close-angle Glaucoma Picture
Figure United States Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Latanoprost Revenue (Million USD) and Growth Rate (2012-2022)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Latanoprost Type and Applications
Table Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Latanoprost Type and Applications
Table Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Latanoprost Type and Applications
Table Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Latanoprost Type and Applications
Table Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Latanoprost Type and Applications
Table Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharma Basic Information, Manufacturing Base and Competitors
Table Taj Pharma Latanoprost Type and Applications
Table Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CR Zizhu Basic Information, Manufacturing Base and Competitors
Table CR Zizhu Latanoprost Type and Applications
Table CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Latanoprost Sales by Manufacturer (2016-2017)
Figure North America Latanoprost Sales Market Share by Manufacturer in 2016
Figure North America Latanoprost Sales Market Share by Manufacturer in 2017
Table North America Latanoprost Revenue by Manufacturer (2016-2017)
Figure North America Latanoprost Revenue Market Share by Manufacturer in 2016
Figure North America Latanoprost Revenue Market Share by Manufacturer in 2017
Table North America Latanoprost Price by Manufacturers (2016-2017)
Figure Top 3 Latanoprost Manufacturer Market Share in 2016
Figure Top 3 Latanoprost Manufacturer Market Share in 2017
Figure Top 5 Latanoprost Manufacturer Market Share in 2016
Figure Top 5 Latanoprost Manufacturer Market Share in 2017
Figure North America Latanoprost Sales and Growth (2012-2017)
Table North America Latanoprost Sales by Countries (2012-2017)
Table North America Latanoprost Sales Market Share by Countries (2012-2017)
Figure North America 2012 Latanoprost Sales Market Share by Countries
Figure North America 2016 Latanoprost Sales Market Share by Countries
Figure North America Latanoprost Revenue and Growth (2012-2017)
Table North America Latanoprost Revenue by Countries (2012-2017)
Table North America Latanoprost Revenue Market Share by Countries (2012-2017)
Table North America 2012 Latanoprost Revenue Market Share by Countries
Table North America 2016 Latanoprost Revenue Market Share by Countries
Table North America Latanoprost Sales by Type (2012-2017)
Table North America Latanoprost Sales Share by Type (2012-2017)
Table North America Latanoprost Revenue by Type (2012-2017)
Table North America Latanoprost Revenue Share by Type (2012-2017)
Figure North America Brand Drug Sales Growth (2012-2017)
Figure North America Brand Drug Price (2012-2017)
Figure North America Generic Drug Sales Growth (2012-2017)
Figure North America Generic Drug Price (2012-2017)
Table North America Latanoprost Sales by Application (2012-2017)
Table North America Latanoprost Sales Share by Application (2012-2017)
Figure North America Open-angle Glaucoma Sales Growth (2012-2017)
Figure North America Close-angle Glaucoma Sales Growth (2012-2017)
Figure United States Latanoprost Revenue and Growth (2012-2017)
Figure United States Latanoprost Sales and Growth (2012-2017)
Table United States Latanoprost Sales by Type (2012-2017)
Table United States Latanoprost Sales Market Share by Type (2012-2017)
Table United States Latanoprost Sales by Application (2012-2017)
Table United States Latanoprost Sales Market Share by Application (2012-2017)
Table United States Latanoprost Sales by Manufacturer (2016-2017)
Figure United States Latanoprost Sales Market Share by Manufacturer in 2016
Figure United States Latanoprost Sales Market Share by Manufacturer in 2017
Table United States Latanoprost Revenue by Manufacturer (2016-2017)
Figure United States Latanoprost Revenue Market Share by Manufacturer in 2016
Figure United States Latanoprost Revenue Market Share by Manufacturer in 2017
Table United States Latanoprost Export and Import (2012-2017)
Figure Canada Latanoprost Revenue and Growth (2012-2017)
Figure Canada Latanoprost Sales and Growth (2012-2017)
Table Canada Latanoprost Sales by Type (2012-2017)
Table Canada Latanoprost Sales Market Share by Type (2012-2017)
Table Canada Latanoprost Sales by Application (2012-2017)
Table Canada Latanoprost Sales Market Share by Application (2012-2017)
Table Canada Latanoprost Sales by Manufacturer (2016-2017)
Figure Canada Latanoprost Sales Market Share by Manufacturer in 2016
Figure Canada Latanoprost Sales Market Share by Manufacturer in 2017
Table Canada Latanoprost Revenue by Manufacturer (2016-2017)
Figure Canada Latanoprost Revenue Market Share by Manufacturer in 2016
Figure Canada Latanoprost Revenue Market Share by Manufacturer in 2017
Table Canada Latanoprost Export and Import (2012-2017)
Figure Mexico Latanoprost Revenue and Growth (2012-2017)
Figure Mexico Latanoprost Sales and Growth (2012-2017)
Table Mexico Latanoprost Sales by Type (2012-2017)
Table Mexico Latanoprost Sales Market Share by Type (2012-2017)
Table Mexico Latanoprost Sales by Application (2012-2017)
Table Mexico Latanoprost Sales Market Share by Application (2012-2017)
Table Mexico Latanoprost Sales by Manufacturer (2016-2017)
Figure Mexico Latanoprost Sales Market Share by Manufacturer in 2016
Figure Mexico Latanoprost Sales Market Share by Manufacturer in 2017
Table Mexico Latanoprost Revenue by Manufacturer (2016-2017)
Figure Mexico Latanoprost Revenue Market Share by Manufacturer in 2016
Figure Mexico Latanoprost Revenue Market Share by Manufacturer in 2017
Table Mexico Latanoprost Export and Import (2012-2017)
Figure North America Latanoprost Sales, Revenue and Growth Rate (2017-2022)
Table North America Latanoprost Sales Forecast by Countries (2017-2022)
Table North America Latanoprost Market Share Forecast by Countries (2017-2022)
Figure United States Latanoprost Sales Forecast (2017-2022)
Figure Canada Latanoprost Sales Forecast (2017-2022)
Figure Mexico Latanoprost Sales Forecast (2017-2022)
Table North America Latanoprost Sales Forecast by Type (2017-2022)
Table North America Latanoprost Market Share Forecast by Type (2017-2022)
Table North America Latanoprost Sales Forecast by Application (2017-2022)
Table North America Latanoprost Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Latanoprost
Figure Manufacturing Process Analysis of Latanoprost
Figure Latanoprost Industrial Chain Analysis
Table Raw Materials Sources of Latanoprost Major Manufacturers in 2016
Table Major Buyers of Latanoprost
Table Distributors/Traders/ Dealers List
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...